TGFβ2 rabbit pAb

CAT:
855-ES8706-01
Size:
50 µL
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
TGFβ2 rabbit pAb - image 1

TGFβ2 rabbit pAb

  • Background :

    This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the an
  • Description :

    This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the an
  • Product Name Alternative :

    Transforming growth factor beta-2 (TGF-beta-2; BSC-1 cell growth inhibitor; Cetermin; Glioblastoma-derived T-cell suppressor factor; G-TSF; Polyergin)
  • UniProt :

    P61812
  • Swiss Prot :

    P61812
  • Reactivity :

    Human; Mouse; Rat
  • Immunogen :

    The antiserum was produced against synthesized peptide derived from human TGF beta2. AA range:361-410
  • Target :

    TGFβ2
  • Clonality :

    Polyclonal
  • Source :

    Rabbit
  • Applications :

    WB; IHC; IF; ELISA
  • Concentration :

    1 mg/ml
  • Dilution :

    WB 1:500-2000, IHC-p 1:500-200, ELISA 1:10000-20000
  • Buffer :

    -20°C/1 year
  • Molecular Weight :

    47+12kD
  • Storage Conditions :

    -20°C/1 year
  • Observed Molecular Weight :

    47+12kD
  • Fragment :

    IgG
  • Subcellular Location :

    [Latency-associated peptide]: Secreted, extracellular space, extracellular matrix .; [Transforming growth factor beta-2]: Secreted .
  • Other Product Names :

    Transforming growth factor beta-2 (TGF-beta-2; BSC-1 cell growth inhibitor; Cetermin; Glioblastoma-derived T-cell suppressor factor; G-TSF; Polyergin)
  • Gene ID (Human) :

    7042

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide